More breast cancer patients prefer BRCA-mutation testing without prior face-to-face genetic counseling

Familial Cancer

Volumn 13, Issue 2, 2014, Pages 143-151

  Sie, Aisha S ^a   Van Zelst Stams, Wendy A G ^a   Spruijt, Liesbeth ^a   Mensenkamp, Arjen R ^a   Ligtenberg, Marjolijn J L ^a   Brunner, Han G ^a   Prins, Judith B ^a   Hoogerbrugge, Nicoline ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

BRCA; Breast cancer; Counseling; DNA; Genetic; Hereditary

Indexed keywords

BRCA1 ASSOCIATED RING DOMAIN PROTEIN 1;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER PATIENT; CONFLICT; CONSULTATION; DISTRESS SYNDROME; FEMALE; FOLLOW UP; GENETIC COUNSELING; GENETIC SCREENING; HETEROZYGOTE; HOME; HUMAN; MAJOR CLINICAL STUDY; MEDICAL INFORMATION; PATIENT PREFERENCE; PATIENT REFERRAL; PATIENT SATISFACTION; PERSONAL EXPERIENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; TELEPHONE; BREAST TUMOR; DECISION MAKING; ETIOLOGY; GENETICS; INFORMATION SEEKING; MENTAL STRESS; MIDDLE AGED; NUCLEOTIDE SEQUENCE; PROCEDURES; PSYCHOLOGY; TIME; TUMOR SUPPRESSOR GENE; YOUNG ADULT;

ADULT; AGED; BREAST NEOPLASMS; CHOICE BEHAVIOR; CONFLICT (PSYCHOLOGY); DNA MUTATIONAL ANALYSIS; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC COUNSELING; GENETIC TESTING; HUMANS; INFORMATION SEEKING BEHAVIOR; MIDDLE AGED; PATIENT PREFERENCE; PROSPECTIVE STUDIES; STRESS, PSYCHOLOGICAL; TIME FACTORS; YOUNG ADULT;

EID: 84903192983     PISSN: 13899600     EISSN: 15737292     Source Type: Journal    
DOI: 10.1007/s10689-013-9686-z     Document Type: Article

References (34)

1. Salemink S, Dekker N, Kets CM, van der Looij E, van Zelst-Stams WA, Hoogerbrugge N (2013) Focusing on patient needs and preferences may improve genetic counseling for colorectal cancer. J Genet Couns 22(1):118-124. doi:10.1007/s10897-012-9519-5
2. Antoniou A, Pharoah PD, Narod S, Risch HA, Eyfjord JE, Hopper JL, Loman N, Olsson H, Johannsson O, Borg A, Pasini B, Radice P, Manoukian S, Eccles DM, Tang N, Olah E, nton-Culver H, Warner E, Lubinski J, Gronwald J, Gorski B, Tulinius H, Thorlacius S, Eerola H, Nevanlinna H, Syrjakoski K, Kallioniemi OP, Thompson D, Evans C, Peto J, Lalloo F, Evans DG, Easton DF (2003) Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72(5):1117-1130 (Pubitemid 36530000)
3. Chen S, Parmigiani G (2007) Meta-analysis of BRCA1 and BRCA2 penetrance. J Clin Oncol 25(11):1329-1333 (Pubitemid 46706879)
4. King MC, Marks JH, Mandell JB (2003) Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 302(5645):643-646 (Pubitemid 37310920)
5. Trainer AH, Lewis CR, Tucker K, Meiser B, Friedlander M, Ward RL (2010) The role of BRCA mutation testing in determining breast cancer therapy. Nat Rev Clin Oncol 7(12):708-717
6. van der Velde NM, Mourits MJ, Arts HJ, de Vries J, Leegte BK, Dijkhuis G, Oosterwijk JC, de Bock GH (2009) Time to stop ovarian cancer screening in BRCA1/2 mutation carriers? Int J Cancer 124(4):919-923
7. Bylund CL, Fisher CL, Brashers D, Edgerson S, Glogowski EA, Boyar SR, Kemel Y, Spencer S, Kissane D (2012) Sources of uncertainty about daughters' breast cancer risk that emerge during genetic counseling consultations. J Genet Couns 21(2):292-304. doi:10.1007/s10897-011-9400-y
8. Kurian AW, Sigal BM, Plevritis SK (2010) Survival analysis of cancer risk reduction strategies for BRCA1/2 mutation carriers. J Clin Oncol 28(2):222-231
9. Henselmans I, Sanderman R, Smink A, Ranchor AV, de Vries J (2010) Waiting times in breast disease clinics and psychological well-being: speedy care is better care. Ned Tijdschr Geneeskd 154:B491
10. van Oostrom I, Tibben A (2004) A counselling model for BRCA1/2 genetic susceptibility testing. Hered Cancer Clin Pract 2(1):19-23
11. Hilgart JS, Coles B, Iredale R (2012) Cancer genetic risk assessment for individuals at risk of familial breast cancer. Cochrane Datab Syst Rev 2:CD003721. doi:10.1002/14651858.CD003721.pub3
12. Kessels RP (2003) Patients' memory for medical information. J R Soc Med 96(5):219-222
13. Overbeek LI, Hermens RP, van Krieken JH, Adang EM, Casparie M, Nagengast FM, Ligtenberg MJ, Hoogerbrugge N (2010) Electronic reminders for pathologists promote recognition of patients at risk for Lynch syndrome: cluster-randomised controlled trial. Virchows Arch 456(6):653-659
14. Landsbergen KM, Prins JB, Brunner HG, Hoogerbrugge N (2011) Shortened time interval between colorectal cancer diagnosis and risk testing for hereditary colorectal cancer is not related to higher psychological distress. Fam Cancer 10(1):51-57
15. Sie AS, Spruijt L, van Zelst-Stams WA, Mensenkamp AR, Ligtenberg MJ, Brunner HG, Prins JB, Hoogerbrugge N (2012) DNA-testing for BRCA1/2 prior to genetic counselling in patients with breast cancer: design of an intervention study, DNA-direct. BMC Womens Health 12:12. doi:10.1186/1472-6874-12-12
16. Pieterse A, van Dulmen S, Ausems M, Schoemaker A, Beemer F, Bensing J (2005) QUOTE-gene(ca): development of a counseleecentered instrument to measure needs and preferences in genetic counseling for hereditary cancer. Psycho-Oncology 14(5):361-375. doi:10.1002/pon.853 (Pubitemid 40674415)
17. Goldberg DP, Gater R, Sartorius N, Ustun TB, Piccinelli M, Gureje O, Rutter C (1997) The validity of two versions of the GHQ in the WHO study of mental illness in general health care. Psychol Med 27(1):191-197 (Pubitemid 27042731)
18. Horowitz M, Wilner N, Alvarez W (1979) Impact of event scale: a measure of subjective stress. Psychosom Med 41(3):209-218 (Pubitemid 9219271)
19. van der Ploeg E, Mooren TT, Kleber RJ, van der Velden PG, Brom D (2004) Construct validation of the Dutch version of the impact of event scale. Psychol Assess 16(1):16-26 (Pubitemid 38339680)
20. Bottomley A, Aaronson NK (2007) International perspective on health-related quality-of-life research in cancer clinical trials: the European Organisation for Research and Treatment of Cancer experience. J Clin Oncol 25(32):5082-5086 (Pubitemid 350232287)
21. Hopwood P, Shenton A, Lalloo F, Evans DG, Howell A (2001) Risk perception and cancer worry: an exploratory study of the impact of genetic risk counselling in women with a family history of breast cancer. J Med Genet 38(2):139
22. Lerman C, Daly M, Masny A, Balshem A (1994) Attitudes about genetic testing for breast-ovarian cancer susceptibility. J Clin Oncol 12(4):843-850 (Pubitemid 24110927)
23. Koedoot N, Molenaar S, Oosterveld P, Bakker P, de Graeff A, Nooy M, Varekamp I, de Haes H (2001) The decisional conflict scale: further validation in two samples of Dutch oncology patients. Patient Educ Couns 45(3):187-193 (Pubitemid 33109005)
24. O'Connor AM (2010) User Manual - Decisional Conflict Scale (16 item statement format). http://decisionaid.ohri.ca/docs/develop/User-Manuals/UM- Decisional-Conflict.pdf
25. Berg S van de, Gielissen MF, Prins JB (2010) Validation of an empowerment questionnaire in breast cancer survivors. In: 12th World Congress of Psycho-Oncology
26. van Oostrom I, Meijers-Heijboer H, Lodder LN, Duivenvoorden HJ, van Gool AR, Seynaeve C, van der Meer CA, Klijn JG, van Geel BN, Burger CW, Wladimiroff JW, Tibben A (2003) Long-term psychological impact of carrying a BRCA1/2 mutation and prophylactic surgery: a 5-year follow-up study. J Clin Oncol 21(20):3867-3874 (Pubitemid 46606243)
27. Comprehensive Cancer Centres the Netherlands (2010) Oncoline Guideline: hereditary breast/ovarian cancer
28. Walsh MC, Trentham-Dietz A, Schroepfer TA, Reding DJ, Campbell B, Foote ML, Kaufman S, Barrett M, Remington PL, Cleary JF (2010) Cancer information sources used by patients to inform and influence treatment decisions. J Health Commun 15(4):445-463. doi:10.1080/10810731003753109
29. Metcalfe KA, Mian N, Enmore M, Poll A, Llacuachaqui M, Nanda S, Sun P, Hughes KS, Narod SA (2012) Long-term follow-up of Jewish women with a BRCA1 and BRCA2 mutation who underwent population genetic screening. Breast Cancer Res Treat 133(2):735-740. doi:10.1007/s10549-011-1941-0
30. Rahman B, Meiser B, Watts K, Gleeson M, Saunders C, Mitchell G, Barlow-Stewart K, Kirk J, Tucker K (2012) Evaluation of the efficacy of two models of delivering information about treatment-focused genetic testing among young women newly diagnosed with breast cancer. Paper presented at the European Meeting on Psychosocial Aspects of Genetics 2012, Nuernberg, Germany, June 25 2012
31. Voorwinden JS, Jaspers JP, ter Beest JG, Kievit Y, Sijmons RH, Oosterwijk JC (2012) The introduction of a choice to learn presymptomatic DNA test results for BRCA or Lynch syndrome either face-to-face or by letter. Clin Genet 81(5):421-429. doi:10.1111/j.1399-0004.2011.01811.x
32. Platten U, Rantala J, Lindblom A, Brandberg Y, Lindgren G, Arver B (2012) The use of telephone in genetic counseling versus in-person counseling: a randomized study on counselees' outcome. Fam Cancer. doi:10.1007/s10689-012- 9522-x
33. Olaya W, Esquivel P, Wong JH, Morgan JW, Freeberg A, Roy-Chowdhury S, Lum SS (2009) Disparities in BRCA testing: when insurance coverage is not a barrier. Am J Surg 198(4):562-565. doi:10.1016/j.amjsurg.2009.07.003
34. Van Riel E, Warlam-Rodenhuis CC, Verhoef S, Rutgers EJ, Ausems MG (2010) BRCA testing of breast cancer patients: medical specialists' referral patterns, knowledge and attitudes to genetic testing. Eur J Cancer Care 19(3):369-376. doi:10.1111/j.1365-2354.2008.01065.x